Over the last few days, media has been abuzz with the news of Sun Pharma’s $4-billion acquisition of Ranbaxy. Given the fact that it is the second largest acquisition in the Indian pharmaceutical sector till date, it is not surprising that everybody is fixated on the sheer size of the deal. But if you look … Continue reading Sun Pharma-Ranbaxy Deal Has Some Important Lessons
Indian Pharma: Regaining Our Brand Equity
Global Impact of India’s Pharma Industry Imagine a scenario where a life-saving medicine for HIV/AIDS costs $12,000 a year, pushing it out of reach for most patients who need it. Or a world where a rotavirus vaccine costs $9 per dose, making it too expensive for most children across the globe. Now, consider a reality where … Continue reading Indian Pharma: Regaining Our Brand Equity
